Coupling Between B Cell Receptor and Phospholipase C-γ2 Is Essential for Mature B Cell Development
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Two signaling pathways known to be essential for progression from immature to mature B cells are BAFF receptor (BAFF-R) and the B cell receptor (BCR). Here, we first show that phospholipase C (PLC)-γ2 is required for a BAFF-R–mediated survival signal. Then, we have examined the question of whether the reduced number of mature B cells in PLC-γ2−/− mice is caused by a defect in either BCR or BAFF-R signaling. We find that a PLC-γ2 SH2 mutant, which inhibits coupling between BCR and PLC-γ2, fails to restore B cell maturation, despite supporting BAFF-dependent survival. Therefore, our data suggest that the BAFF-R–mediated survival signal, provided by PLC-γ2, is not sufficient to promote B cell maturation, and that, in addition, activation of PLC-γ2 by BCR is required for B cell development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Differential gene expression analyses revealed two TCL1A+CD27− naive B cell populations37, including a transitioning subset (PLCG2+ naive B cells) expressing PLCG2, which facilitates the development of mature B cells upon B cell receptor (BCR) activation38, where both naive B cell subsets expressed ICOSLG (Fig. 6c–e).”
From Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis (2025) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clonal selection and learning in the antibody system
Rajewsky, K. (1996) · Nature · doi:10.1038/381751a0 · Cited by 1,709
Lam, K.-P., Kühn, R., & Rajewsky, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80373-6 · Cited by 1,108 · cited 5×
“BCR ablation (10) or BAFF-R mutation (14, 15) results in cell death by apoptosis.”
BackgroundResultInfluentialAn Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway
Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulga-Morskaya, S., Dobles, M., Frew, E., & Scott, M. L. (2001) · Science · doi:10.1126/science.1061964 · Cited by 1,069 · cited 1×
“These mice, like BAFF-deficient mice (16, 17), have a developmental block at the T1 stage, suggesting that either differentiation to the T2 stage and/or survival of T2 cells require BAFF-R signaling.”
BackgroundBAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF
Thompson, J. S., Bixler, S. A., Qian, F., Vora, K., Scott, M. L., Cachero, T. G., Hession, C., Schneider, P., Sizing, I. D., Mullen, C., et al. (2001) · Science · doi:10.1126/science.1061965 · Cited by 889
Loder, B. F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C., & Carsetti, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.75 · Cited by 863 · cited 1×
“Accordingly, in the spleen, B cell development proceeds through the transitional 1 (T1), transitional 2 (T2), and mature follicular B cell stages (4).”
BackgroundMartin, F., & Kearney, J. F. (2002) · Nature Reviews Immunology · doi:10.1038/nri799 · Cited by 860
BAFF: A fundamental survival factor for B cells
Mackay, F., & Browning, J. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri844 · Cited by 743
Baff Mediates Survival of Peripheral Immature B Lymphocytes
Batten, M., Groom, J., Cachero, T. G., Qian, F., Schneider, P., Tschopp, J., Browning, J. L., & Mackay, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1453 · Cited by 704 · cited 4×
“In vitro cultures of T2 B cells were performed according to the previous reports (21, 22).”
BackgroundMethodResultInfluentialBAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
Claudio, E., Brown, K., Park, S., Wang, H., & Siebenlist, U. (2002) · Nature Immunology · doi:10.1038/ni842 · Cited by 693
Regulation of B-cell fate by antigen-receptor signals
Niiro, H., & Clark, E. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri955 · Cited by 629 · cited 1×
“It has been reported that stimulation by both BCR and BAFF-R results in NF- B activation (5, 29).”
Background
Cited by
The follicular versus marginal zone B lymphocyte cell fate decision
Pillai, S., & Cariappa, A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2656 · Cited by 570
“In general, mutations in components of the BCR–BTK pathway, including those in BTK and phospholipase Cγ2 ( PLCγ2”
BackgroundThe role of APRIL and BAFF in lymphocyte activation
Schneider, P. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.04.005 · Cited by 360
“Consistent with a ‘passive’ survival role for BAFF, B cells expressing a phospholipase C (PLC)-g2 mutant enzyme that affects BCR signaling fail to reach the mature stage despite a functional BAFF survival pathway [37].”
BackgroundB Cell Signaling and Fate Decision
Kurosaki, T., Shinohara, H., & Baba, Y. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132541 · Cited by 351
Self-citationAntigen-Receptor Signaling to Nuclear Factor κB
Schulze-Luehrmann, J., & Ghosh, S. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.010 · Cited by 330
Fukami, K., Inanobe, S., Kanemaru, K., & Nakamura, Y. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.06.001 · Cited by 197
Evidence of Marginal-Zone B Cell- Positive Selection in Spleen
Wen, L., Brill-Dashoff, J., Shinton, S. A., Asano, M., Hardy, R. R., & Hayakawa, K. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.007 · Cited by 172
“Since Btk and PLCγ2 are also involved in non-BCR-mediated signaling pathways, such as for IL-5 and BAFF signaling, respectively (Moon et al., 2001; Hikida et al., 2003), it is possible that naive FO B cells may rely more on non-BCR signaling in combination with constitutive tonic BCR signal for…”
BackgroundB Cell Receptor and BAFF Receptor Signaling Regulation of B Cell Homeostasis
Khan, W. N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800933 · Cited by 169
“First, BR3 is also capable of activating the classical NF- B pathway in a Btk- and phospholipase C- 2dependent manner and proceeds via the phosphorylation of IKK and degradation of I B (67, 70).”
Background“A Rose is a Rose is a Rose,” but CVID is Not CVID
Yong, P. F. K., Thaventhiran, J. E. D., & Grimbacher, B. (2011) · Advances in immunology · doi:10.1016/b978-0-12-385991-4.00002-7 · Cited by 160
Yap, D., & Lai, K. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/365083 · Cited by 149
T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytes
Weil, R., & Israël, A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.03.003 · Cited by 125
Shinners, N. P., Carlesso, G., Castro, I., Hoek, K. L., Corn, R. A., Woodland, R. L., Scott, M. L., Wang, D., & Khan, W. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3872 · Cited by 117
“A role for Btk in BAFF-dependent activation of NF- B and B cell survival is consistent with a prior report showing that PLC- 2, a direct substrate of Btk, is also involved in these processes (14).”
BackgroundResultBadr, G., Borhis, G., Lefevre, E. A., Chaoul, N., Deshayes, F., Dessirier, V., Lapree, G., Tsapis, A., & Richard, Y. (2008) · Blood · doi:10.1182/blood-2007-03-081232 · Cited by 114
The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration
Jackson, J. T., Mulazzani, E., Nutt, S. L., & Masters, S. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100905 · Cited by 113
“The incomplete nature of the rescue of PLCγ2 deficiency by Bcl2 overexpression was due to Bcl2 not being able to compensate for an additional function of PLCγ2 in mediating B cell–activating factor receptor signaling, which is also necessary for B cell survival and maturation (33).”
BackgroundThe role of cytokines in the pathogenesis of systemic lupus erythematosus – from bench to bedside
Yap, D. Y. H., & Lai, K. N. (2013) · Nephrology · doi:10.1111/nep.12047 · Cited by 114
Ouchida, R., Yamasaki, S., Hikida, M., Masuda, K., Kawamura, K., Wada, A., Mochizuki, S., Tagawa, M., Sakamoto, A., Hatano, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.024 · Cited by 76
“Ca2+ influx experiments were performed as previously described (Hikida et al., 2003).”
MethodSelf-citationPLC-γ2 is essential for formation and maintenance of memory B cells
Hikida, M., Casola, S., Takahashi, N., Kaji, T., Takemori, T., Rajewsky, K., & Kurosaki, T. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082100 · Cited by 73
Self-citationThe Biochemistry and Biology of BAFF, APRIL and Their Receptors
Kalled, S. L., Ambrose, C. M., & Hsu, Y. (2004) · KARGER eBooks · doi:10.1159/000082105 · Cited by 76
Foerster, C., Voelxen, N., Rakhmanov, M., Keller, B., Gutenberger, S., Goldacker, S., Thiel, J., Feske, S., Peter, H.-H., & Warnatz, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000434 · Cited by 72
DeKoter, R. P., Geadah, M., Khoosal, S., Xu, L. S., Thillainadesan, G., Torchia, J., Chin, S. S., & Garrett-Sinha, L. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001413 · Cited by 50
“encoding proteins important for BCR signaling, such as Btk or PLCg2, cause reductions in the frequency of FO B cells in the spleen and increases in the frequency of MZ B cells (10, 11).”
BackgroundVav proteins regulate peripheral B-cell survival
Vigorito, E., Gambardella, L., Colucci, F., McAdam, S., & Turner, M. (2005) · Blood · doi:10.1182/blood-2004-12-4894 · Cited by 50
B Cell-Activating Factor Is a Novel Diagnosis Parameter for Asthma
Kang, J. S., Yoon, Y.-D., Ahn, J., Kim, S. C., Kim, K.-H., Kim, H., & Moon, E. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000094897 · Cited by 50
“However, the functions of BAFF receptors, BAFF-R and TACI, have not yet been defined but it is expected that they function differently in T cells. Our data suggest that CD3+ T cells may communicate with either APCs or CD19+ B cells through BAFF-R or TACI in which BAFF may act as a communication bridge between T and B…”
BackgroundChicken B‐Cell‐Activating Factor: Regulator of B‐Cell Survival in the Bursa of Fabricius
Koskela, K., Nieminen, P., Kohonen, P. J., Salminen, H., & Lassila, O. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01418.x · Cited by 46
Martin, O. P., Wallace, M. S., Oetheimer, C., Patel, H. B., Butler, E. C., Wong, L. P., Huang, P., Elbaz, J., Costentin, C., Salloum, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02255-y · Cited by 45
“…analyses revealed two TCL1A + CD27 − naive B cell populations 37 , including a transitioning subset ( PLCG2 + naive B cells) expressing PLCG2 , which facilitates the development of mature B cells upon B cell receptor (BCR) activation 38 , where both naive B cell sub-sets expressed ICOSLG (Fig.”
Hoek, K. L., Antony, P., Lowe, J. A., III, Shinners, N. P., Sarmah, B., Wente, S. R., Wang, D., Gerstein, R. M., & Khan, W. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5405 · Cited by 42
“These observations support an active role for BCR signaling, particularly the BTK/PLC- 2 signaling axis, in the differentiation of T2 into mature FoB cells (3, 4, 15, 25, 26, 28).”
BackgroundRoles of Phospholipase C Isozymes in Organogenesis and Embryonic Development
Nakamura, Y., & Fukami, K. (2009) · Physiology · doi:10.1152/physiol.00031.2009 · Cited by 41
A therapeutic role for BLyS antagonists
Stohl, W. (2004) · Lupus · doi:10.1191/0961203304lu1019oa · Cited by 36
Bell, S. E., Vigorito, E., McAdam, S., Reynolds, H., Caraux, A., Colucci, F., & Turner, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425054 · Cited by 31
Xu, S., Lee, K.-G., Huo, J., Kurosaki, T., & Lam, K. (2006) · Blood · doi:10.1182/blood-2006-07-036418 · Cited by 26
Self-citationHuman SLP-65 isoforms contribute differently to activation and apoptosis of B lymphocytes
Grabbe, A., & Wienands, J. (2006) · Blood · doi:10.1182/blood-2006-02-005397 · Cited by 29
“activation can be explained by the observation that this pathway requires the SLP-65 effector PLC-γ2 and its enzymatic product diacylglycerol.(46,47) Both SLP-65 isoforms couple however to PLC-γ2 with similar efficiency.”
BackgroundStohl, W. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.3.177 · Cited by 23
“Phospholipase C-γ2 is activated [43] as are both NF-κB1 and -2 via discrete pathways [44-46].”
BackgroundMagari, M., Nishikawa, Y., Fujii, Y., Nishio, Y., Watanabe, K., Fujiwara, M., Kanayama, N., & Ohmori, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100934 · Cited by 25
Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas
Huynh, M. Q., Wacker, H., Wündisch, T., Sohlbach, K., Kim, T. D., Krause, M., Stabla, K., Roth, P., Fischbach, W., Stolte, M., et al. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802007734 · Cited by 22
Rac-mediated stimulation of phospholipase Cγ2 amplifies B cell receptor-induced calcium signaling
Walliser, C., Tron, K., Clauss, K., Gutman, O., Kobitski, A. Y., Retlich, M., Schade, A., Röcker, C., Henis, Y. I., Nienhaus, G. U., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645739 · Cited by 21
Sanjo, H., Hikida, M., Aiba, Y., Mori, Y., Hatano, N., Ogata, M., & Kurosaki, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01530-06 · Cited by 20
“4G2) (all from BD Bioscience); anti-IgD (11-26) (from Southern Biotechnol-”
Self-citationRegulation of Phospholipase C‐γ2 Networks in B Lymphocytes
Hikida, M., & Kurosaki, T. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)88003-4 · Cited by 24
Self-citationYu, M., Chen, Y., He, Y., Podd, A., Fu, G., Wright, J. A., Kleiman, E., Khan, W. N., Wen, R., & Wang, D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102952 · Cited by 19
“1 (CD93; 13-5892), PE-conjugated anti-CD23 (12-0232), and PE-Cy7–conjugated streptavidin (25-4317) were purchased from eBioscience.”
Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation
Lee, P., Zhu, Z., Hachmann, J., Nojima, T., Kitamura, D., Salvesen, G. S., & Rickert, R. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502518 · Cited by 15
“hibit a loss of FO B cells but normal MZ structure (67, 68), deletion of any of the CBM complex components results in a substantial decrease in MZ B cells (44, 69).”
BackgroundProximal B cell receptor signaling pathways
Skaggs, B. J., & Clark, M. R. (2004) · Signal Transduction · doi:10.1002/sita.200400034 · Cited by 15
Phospholipase Cγ2 Dosage Is Critical for B Cell Development in the Absence of Adaptor Protein BLNK
Xu, S., Huo, J., Chew, W.-K., Hikida, M., Kurosaki, T., & Lam, K.-P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4690 · Cited by 12
“the B cell activating factor belonging to the TNF family receptor (BAFF-R) signaling pathway also appears to use PLC 2 (20) but not BLNK (data not shown).”
BackgroundSelf-citationMolecular cloning, expression and bioactivity of B cell activating factor (BAFF) in African ostrich
Yang, K., Xiao, K., Huang, H., Lu, S., Zhong, J., Ansari, A. R., Khaliq, H., Song, H., Liu, H., & Peng, K. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.043 · Cited by 11
“The survival signal of BAFF to B cells is dependent also on BCRmediated signaling [39].”
BackgroundLupus érythémateux systémique: Traitements par anticorps monoclonaux et molécules recombinantes
Terrier, B., & Mouthon, L. (2013) · médecine/sciences · doi:10.1051/medsci/2013291015 · Cited by 11
“In vitro, BAFF agit comme un costimulateur du BCR (B-cell receptor), et, de ce fait, augmente la survie du lymphocyte B, via la stimulation des facteurs de transcription inhibiteurs de l’apoptose [12].”
Expression and pro-survival function of phospholipase Cγ2 in diffuse large B-cell lymphoma
Huynh, M. Q., Goßmann, J., Gattenlöehner, S., Klapper, W., Wacker, H.-H., Ramaswamy, A., Bittner, A., Kaiser, U., & Neubauer, A. (2015) · Leukemia & Lymphoma · doi:10.3109/10428194.2014.941832 · Cited by 8
Lee, G., Oh, J., Kim, H.-S., Yoon, W., Yi, K. Y., Yang, Y. D., Han, S. H., Lee, S., & Moon, E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.026 · Cited by 7
Moon, E., Yi, K. Y., & Lee, S. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.009 · Cited by 6
Arthur, R., Wathen, A., Lemm, E. A., Stevenson, F. K., Forconi, F., Linley, A. J., Steele, A. J., Packham, G., & Valle‐Argos, B. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110358 · Cited by 5
BAFF Receptor Regulation of Peripheral B-Lymphocyte Survival and Development
Khan, W. N., Shinners, N. P., Castro, I., & Hoek, K. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-013-7_2 · Cited by 5
“Recent studies indicating that PLC-γ2 is required for BR3-mediated activation of NF-κB suggest an involvement of the Btk substrate, PLC-γ2, in BAFFinduced NF-κB activation [128].”
BackgroundDistinct roles of BCNP1 in B-cell development and activation
Hong, R., Lai, N., Xiong, E., Ouchida, R., Sun, J., Zhou, Y., Tang, Y., Hikida, M., Tsubata, T., Tagawa, M., et al. (2019) · International Immunology · doi:10.1093/intimm/dxz055 · Cited by 4
Self-citationSelf-nonself Recognition through B-Cell Antigen Receptor
Kitamura, D. (2008) · Springer eBooks · doi:10.1007/978-4-431-73884-8_4 · Cited by 2
“Btk, BLNK, PLCγ2, PI3K p85α, and PKCβ have been shown to be necessary for BCR signal leading to NF-κB activation (Bajpai et al. 2000; Hikida et al. 2003; Petro and Khan 2001; Petro et al. 2000; Saijo et al. 2002; Su et al. 2002; Suzuki et al. 2003; Tan et al. 2001).”
BackgroundAntony, P., Hoek, K. L., Sarmah, B., & Khan, W. N. (2007) · PubMed Central · doi:10.1251/bpo135 · Cited by 3
Meudec, L., Nocturne, G., & Xavier Mariette, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15051945 · Cited by 2
“BAFF acts as a BCR (B-cell Receptor) co-stimulator [44], enhancing B-cell proliferation, differentiation, and antibody secretion, and can induce class switching independently of CD40 ligand [45].”
Nojima, T., Hayashi, K., Goitsuka, R., Nakayama, K., Nakayama, K., & Kitamura, D. (2006) · Immunology Letters · doi:10.1016/j.imlet.2005.12.004 · Cited by 2
Structure and Signaling Function of the B-Cell Antigen Receptor and Its Coreceptors
Reth, M. G., Nitschke, L., Hikida, M., & Kurosaki, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00010-2 · Cited by 4
Self-citationT-independent B-cell effect of agents associated with swine grower-finisher diarrhea
Barbosa, J. A., Yang, C. T., Finatto, A. N., Cantarelli, V. S., & Costa, M. D. O. (2023) · Veterinary Research Communications · doi:10.1007/s11259-023-10257-0 · Cited by 1
“These molecules form the main BCR signaling cascade involved in B lymphocyte cell-cycle progression and survival pathways (Fruman et al. 1999 ; Hikida et al. 2003 ).”
Systemic Immune-Based Rheumatic Diseases: Blissless States of BLySfulness
Stohl, W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-013-7_8
Regulation of B Cell Gene Expression and Function by Ikaros, Helios and Bcl6
Alinikula, J. (2010) · UTUPub (University of Turku) · Cited by 1
Almaden, J. (2013) · eScholarship (California Digital Library)
Marginal Zone B Cell Development
Demissie, E., Rosenberg, I. M., & Pillai, S. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.01014-6
Kaur, P. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-70603-0_3
Signaling regulation of transitional immature to mature B cell development
Llanes, J. M. (2006)
Marginal Zone B Cell Development
Pillai, S. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00255-6
Neutrophil extracellular traps et hémorragie intra-alvéolaire
Jarrot, P. (2018) · theses.fr (ABES) · doi:10.70675/dd1145e2z3f6dz4fe4zbcf2za76a90fe43ac
Rôle des cellules épithéliales salivaires au cours du Syndrome de Sjögren primitif
Rivière, É. (2020) · theses.fr (ABES) · doi:10.70675/4828f598z5b6cz4f70zbacbzf35ad1f4fad4
Metadata
- Authors
- Hikida, M., Johmura, S., Hashimoto, A., Takezaki, M., & Kurosaki, T.
- Affiliations
- Kansai Medical University (JP)
- RIKEN (JP)
- Corresponding author
- Kurosaki, Tomohiro
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-11
- Volume
- 198
- Issue
- 4
- Pages
- 581-589
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194178
- OpenAlex
- W2097494683
- Cited by
- 62
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- B cell receptor, PLCγ2, BAFF receptor, B cell maturation, B cell survival, SH2 domain, B cell development
- MeSH terms
- Animals, B-Lymphocytes, Bone Marrow Cells, Cell Survival, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Type C Phospholipases, Receptors, Antigen, B-Cell, Spleen, Signal Transduction, NF-kappa B, Receptors, Tumor Necrosis Factor, Genes, bcl-2, Mice, Phospholipase C gamma, B-Cell Activation Factor Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.